Association Between Proton Pump Inhibitors and Microscopic Colitis

American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis

(2016) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

American Gastroenterological Association Institute Technical Review on the Medical Management of Microscopic Colitis

(2016) Darrell S. Pardi et al.   GASTROENTEROLOGY

Increased Risk of Microscopic Colitis With Use of Proton Pump Inhibitors and Non-Steroidal Anti-Inflammatory Drugs

(2015) Gwen M C Masclee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Collagenous Colitis Associated with Rabeprazole in a Peritoneal Dialysis Patient

(2015) M. Murasawa et al.   PERITONEAL DIALYSIS INTERNATIONAL

Drug Exposure and Risk of Microscopic Colitis

(2014) Ole K. Bonderup et al.   INFLAMMATORY BOWEL DISEASES

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

(2014) Erik von Elm et al.   International Journal of Surgery

Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis

(2013) J. Umeno et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Impact of Current Smoking on the Clinical Course of Microscopic Colitis

(2013) Fernando Fernández-Bañares et al.   INFLAMMATORY BOWEL DISEASES

Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis

(2012) Wai–Kit Lo et al.   Clinical Gastroenterology and Hepatology

Proton Pump Inhibitors and Risk of Fractures: A Meta-Analysis of 11 International Studies

(2011) Elaine W. Yu et al.   AMERICAN JOURNAL OF MEDICINE

Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis

(2011) Abhishek Deshpande et al.   Clinical Gastroenterology and Hepatology

Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study

(2010) D. Keszthelyi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Lansoprazole-induced microscopic colitis: An increasing problem? Results of a prospecive case-series and systematic review of the literature

(2010) Gabriele Capurso et al.   DIGESTIVE AND LIVER DISEASE

Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis

(2010) E. Nomura et al.   ENDOSCOPY

Use of protonpump inhibitors and risk of hip fracture

(2009) A. Lalmohamed et al.   BONE

Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis

(2009) H. Yusuke et al.   ENDOSCOPY

Microscopic Colitis Associated With Omeprazole and Esomeprazole Exposure

(2009) Gilbert M. Wilcox et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Lansoprazole-associated collagenous colitis: Diffuse mucosal cloudiness mimicking ulcerative colitis

(2009) Mitsuro Chiba et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase

(2008) J. M. MULLIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transmucosal Gastric Leak Induced by Proton Pump Inhibitors

(2008) Lisa J. Murray et al.   DIGESTIVE DISEASES AND SCIENCES

Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis

(2008) Junji Umeno et al.   GASTROINTESTINAL ENDOSCOPY